Lannett Company, Inc. (NYSE:LCI)

CAPS Rating: 2 out of 5

The Company develops, manufactures, markets and distributes generic versions of pharmaceutical products.

Results 1 - 16 of 16

Recs

1
Member Avatar GAGA (< 20) Submitted: 2/5/2014 11:49:45 AM : Outperform Start Price: $36.23 LCI Score: -10.84

OBAMA CARE

Recs

0
Member Avatar Coreylan (< 20) Submitted: 12/26/2013 11:33:38 PM : Outperform Start Price: $36.23 LCI Score: -10.84

Affordable Care Act

Recs

1
Member Avatar tomi1970 (43.89) Submitted: 11/6/2013 10:22:00 PM : Underperform Start Price: $24.40 LCI Score: -28.96

cannot justify value at 23, see it at 9

Recs

0
Member Avatar gunterle (63.88) Submitted: 4/10/2013 2:04:53 PM : Outperform Start Price: $10.61 LCI Score: +195.15

signal

Recs

0
Member Avatar xaneti (71.24) Submitted: 1/18/2013 5:52:53 PM : Outperform Start Price: $5.90 LCI Score: +439.49

charles schwab screener A+ Pharma Generic low PEG < 1

Recs

0
Member Avatar worknhard (< 20) Submitted: 1/30/2012 10:30:15 AM : Outperform Start Price: $4.89 LCI Score: +539.20

FDA approvals opened up after 483's were fixed.
Backlog of approvals to come
Cody labs starting to hit stride and provide profits.

Recs

0
Member Avatar maniacdog (32.70) Submitted: 6/21/2011 10:14:22 AM : Outperform Start Price: $5.28 LCI Score: +487.47

Looks like morphine sulfate is the rage.

Recs

0
Member Avatar stktrdr1 (< 20) Submitted: 11/6/2010 10:34:17 PM : Outperform Start Price: $6.25 LCI Score: +379.93

LCI seems to have plans for new products and marketing they look as if they will do well over the next few months holding their own while the market makes the necessasry corrections.

Recs

0
Member Avatar meberlein (< 20) Submitted: 8/3/2009 8:36:11 AM : Outperform Start Price: $8.64 LCI Score: +194.07

The stock has been on the rise as of late and is doing so on the back of solid financials. The company in the past five years has had a top out in the low twenties with similiar data to what it is displaying currently. 200% increase within the next 1-2 years.

Recs

0
Member Avatar VoodooEconomist (41.50) Submitted: 4/14/2009 3:21:30 PM : Underperform Start Price: $5.79 LCI Score: -349.84

Correction only

Recs

1
Member Avatar FinancialModeler (27.03) Submitted: 3/11/2009 4:08:43 PM : Underperform Start Price: $5.30 LCI Score: -363.64

Whoever said this stock is under valued needs to learn what value really is. LCI has a PE ratio over 100. The stock trades within 10% of its 52 week high. Returns on assets, equity, and capital is almost nothing. No dividend. Less than 2% profit margin is weak. This is not value.

I want to see this stock drop down to $3 per share before I close this out.

Recs

0
Member Avatar meetme25 (23.41) Submitted: 10/11/2007 12:20:00 AM : Outperform Start Price: $4.63 LCI Score: +597.01

Insider buys

Recs

0
Member Avatar obiwankenobe1250 (92.05) Submitted: 12/10/2006 9:01:16 PM : Outperform Start Price: $6.69 LCI Score: +357.48

Great business in a growth industry. Fundamentals look real solid.

Recs

0
Member Avatar workinharder (< 20) Submitted: 12/7/2006 10:25:01 PM : Outperform Start Price: $6.66 LCI Score: +359.41

New facilities, managment team refocused, many applications awaiting approval.

Recs

0
Member Avatar RandyWill (94.46) Submitted: 11/26/2006 2:02:03 PM : Outperform Start Price: $7.00 LCI Score: +333.96

Seems underpriced given earnings projected by the lone analyst. Haven't had time to really dig into it though.

Recs

0
Member Avatar fsrodrigu7 (< 20) Submitted: 10/1/2006 2:43:52 PM : Outperform Start Price: $5.32 LCI Score: +478.26

beaten, high value, lhigh growth, low price, rebounding

Results 1 - 16 of 16

Featured Broker Partners


Advertisement